THE WORLD’S LEADING AI IN MEDICINE SUMMIT

Bringing together a unique ecosystem of clinicians, technologists and C-Suite executives
Creating a future where AI will revolutionise health
Gain 20 CPD points by attending world-class medical presentations

11TH – 12TH SEPTEMBER 2019

BASEL SWITZERLAND

BOOK NOW

2000
ATTENDEES

100+
SPEAKERS

72%
SENIOR DECISION MAKERS

100+
COUNTRIES

A global summit dedicated to AI in healthcare – And CPD Accredited ! 

In 2018, the summit welcomed 1,612 attendees from 68 countries , 70 of the most influential people in AI and health as speakers and the entire global AI health ecosystem of

  • Pharmaceutical, biotech, medtech, health provision, insurance, investment, science
  • Clinicians across Oncology, Medicinal Chemistry, Cell Therapy, Cancer, Rare diseases, Biosimilars, Radiology, Pathology, Imaging, Diabetes, Ophthalmology, Cardiac, Diagnostics
  • The biggest national hospitals and health systems in Europe
  • The world’s largest pharmaceutical companies
  • The top health regulator on AI in the US
  • And many more…

In 2019, the global AI and health community will gather again in Switzerland to progress discussion about how AI can be used to prevent and solve some of the world’s greatest healthcare problems, improve the health of the human race and set the global AI agenda in healthcare for 2020 and beyond.

WHAT ATTENDEES SAY

Inspiring, Energizing. Thoughtful. Provocative.

Strategic advisor to CEOs of digital health, STEM and education initiatives

Lesley-Anne Long & Associates

The conference was unlike any I've attended before -- I particularly liked the organizational structure; the format of the panels; and the introductions each day by the DJ -- which was a real nice touch. It was a unique combination of science and glamour -- all presented in a format that kept my full attention.

Co-Founder and Chief Science Officer

Lapetus

A great pioneering event that gets health care providers, hospitals, data scientists, startups and corporates together to talk about challenges and disruptive changes and how to get them realised. Great energy and great insights, looking forward to the next edition.

Consultant Cardiac Anaesthetist, AMC & Founder

Healthplus.ai

Intelligent Heath was a catalyzer for different players impacting the heathcare ecosystem

Director
Roche

SPEAKERS 2018

BAKUL PATEL

Associate Centre Director for Digital Health

FDA

BAKUL PATEL

Associate Centre Director for Digital Health

FDA

With AI being a system that continuously learns, the FDA will find it hard to approve AI based devices, as currently, approvals are for products and devices exactly as they are – not for something which changes.

 

Bakul Patel has recently launched a pilot program, “FDA Pre-Cert,” which could eventually allow agency officials to focus their inspections on “the software developer or digital-health technology developer, rather than primarily at the product.’’

 

We are evolving that space,” he says. “The legacy model is the one we know works. But the model that works continuously—we don’t yet have something to validate that. So the question is [as much] scientific as regulatory: How do you reconcile real-time learning [with] people having the same level of trust and confidence they had yesterday?” This is the question he will try to answer with an FDA update at the summit.

JOSE PEDRO ALMEIDA

DIRECTOR OF BIG DATA ANALYTICS & MACHINE LEARNING

São João Hospital Center

JOSE PEDRO ALMEIDA

DIRECTOR OF BIG DATA ANALYTICS & MACHINE LEARNING

São João Hospital Center

He was named top-20 Portuguese world changer and he is a leading expert in the real-world application of Advanced Analytics & Machine Learning to hospital problems, transforming sparse patient’s Big Data into actionable clinical insights. His team built one of the most outstanding Hospital Big Data platforms currently working in EU hospitals. This platform behaves like a “Data Robot” that captures and analyses 560 billion patient data points\minute, coming from 30 different systems, to predict and signal at-risk patients for clinical deterioration up to 7 days in advance. This work has received some of the highest in the industry, amongst which the 1st prize in the HIMSS Europe Digital Healthcare 2016 Award (Barcelona), the 1st prize in the “2014 Microsoft Worldwide Health Innovation Award (MSHUG)” (Orlando, USA) and the 2014 “Big Data & Analytics Solution of the Year” prize by IT Europa (London, UK).

GARY MARCUS

Professor of Psychology and Neural Science

New York University

GARY MARCUS

Professor of Psychology and Neural Science

New York University

Gary Marcus, scientist, bestselling author, entrepreneur, and AI contrarian, was CEO and Founder of the machine learning startup Geometric Intelligence, recently acquired by Uber.

 

As a Professor of Psychology and Neural Science at NYU, he has published extensively in fields ranging from human and animal behaviour to neuroscience, genetics, and artificial intelligence, often in leading journals such as Science and Nature. He is launching a startup focusing on artificial general intelligence focusing on healthcare.

DR. OLIVER MORGAN

Director of Health Emergency and Risk Assessment – WHO Health Emergencies Program

World Health Organization

DR. OLIVER MORGAN

Director of Health Emergency and Risk Assessment – WHO Health Emergencies Program

World Health Organization

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program. From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone).From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic. Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala. Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts. Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries. Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

SALVATORE SCALZO

Policy and Legal Officer

European Commission

SALVATORE SCALZO

Policy and Legal Officer

European Commission

Salvatore Scalzo has been working for more than seven years in the European Commission. Since November 2013, he is Policy and Legal Officer in the Unit dealing with legislation on medical devices (currently unit D4 of the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs). After having dealt with the negotiations of the proposed new Regulations on medical devices which were adopted in spring 2017, he is currently working on the legal interpretation and implementation of those Regulations and coordinating, among other tasks, the activities of the European Commission Expert Groups on medical device identification and traceability and medical software. 

BERTRAND BODSON

Chief Digital Officer

Novartis

BERTRAND BODSON

Chief Digital Officer

Novartis

Bertrand Bodson has been Chief Digital Officer of Novartis since January 1, 2018. He is a member of the Executive Committee of Novartis.

 

From 2013 to 2017, Mr. Bodson served as Chief Digital and Marketing Officer of Sainsbury’s Argos, where he led Argos’ successful transformation from a traditional catalogue business to the third-largest online retailer in the United Kingdom.

 

Prior to that, he was Executive Vice President of the global digital business at EMI Music from 2010 to 2013. He co-founded Bragster.com, a social networking and content sharing website, and has also held senior roles at Amazon.

 

Mr. Bodson earned a Master of Business Administration from Harvard Business School in the United States, where he was a Baker Scholar, and a master’s degree in commercial engineering from the Solvay Business School (Belgium)/McGill University (Canada). He is a member of the Board of Directors of Electrocomponents PLC.

DR. INDRA JOSHI

Clinical Lead – Digital Experience, Digital Urgent & Emergency Care

NHS England

DR. INDRA JOSHI

Clinical Lead – Digital Experience, Digital Urgent & Emergency Care

NHS England

Dr Indra Joshi is Clinical Lead for NHS England’s digital experience programme. She has an overarching knowledge of the national patient-facing digital initiatives within the NHS with a focus on real world evidence, data and digital health tools standards.

 

Indra has a unique portfolio with experience stretching across policy, governance, digital health and marketing, national project strategy and implementation; whilst remaining true to her professional training in emergency medicine.

 

She is the Clinical Director of One HealthTech, a network which champions and supports underrepresented groups in health innovation, particularly women, to be the future leaders in healthcare. Indra, a mother-of-two, is also a Vice Chair for the British Computer Society (Health), an international speaker and consultant on digital health, an expedition medic.

DR. LYNN MCGRATH

Resident Physician, Neurological Surgery and Co-Founder

University of Washington and PupilScreen

DR. LYNN MCGRATH

Resident Physician, Neurological Surgery and Co-Founder

University of Washington and PupilScreen

STEVE GUISE

Global Head of Informatics

Roche Pharmaceuticals

STEVE GUISE

Global Head of Informatics

Roche Pharmaceuticals

Steve Guise has been Global Head of Informatics for Roche Pharmaceuticals since October 2016. During these nearly two years, Steve has built and led a new informatics organization focused on business partnering and driving technology innovation to address business challenges — to ultimately benefit patients.

Steve joined Roche in 2008 as Basel Site Head, Pharma Research Informatics. In 2010, he became Global Head of Scientific Information Systems and Principal Architect, Pharma Research and Early Development (pRED) Informatics. Steve was Head of Pharma Informatics for Asia Pacific based in Shanghai and Singapore for three years. He then took on the role of Head of Diagnostics Information Solutions Software Center of Excellence before being appointed Global Head of Informatics.

Steve is passionate about finding new ways to more effectively bring medical innovation to our patients, particularly where the application of technology can bring about a step change.

Prior to joining Roche, Steve held various IT and management positions at Astra Zeneca in the UK. He has a Master’s degree in Chemistry from The University of St Andrews (UK).

RICCARDO MIOTTO

Senior Data Scientist

Icahn School of Medicine, Mount Sinai

RICCARDO MIOTTO

Senior Data Scientist

Icahn School of Medicine, Mount Sinai

Riccardo Miotto is a senior data scientist in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York and a member of the Institute for Next Generation Healthcare. Riccardo’s work encompasses the design of algorithms for information retrieval, machine learning and data mining applied to clinical data for personalized medicine and medical search engines. Previously, Riccardo worked on clinical trial search engines through free-text eligibility criteria processing and machine learning applied to music information retrieval, in the particular semantic discovery and recommendation, automatic tagging, and cover identification. Riccardo obtained his Ph.D. in Information Engineering from the University of Padova, Italy.

ALESSANDRO CURIONI

IBM Fellow, Vice President Europe and Director

IBM Research

ALESSANDRO CURIONI

IBM Fellow, Vice President Europe and Director

IBM Research

Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and director of the IBM Research Lab in Zurich, Switzerland. He was also recently appointed as the Watson IoT Research Relationship Executive.

 

Dr. Curioni is an internationally recognized leader in the area of high-performance computing and computational science, where his innovative thinking and seminal contributions have helped solve some of the most complex scientific and technological problems in healthcare, aerospace, consumer goods and electronics. He was a member of the winning team recognized with the prestigious Gordon Bell Prize in 2013 and 2015.

 

Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his PhD from Scuola Normale Superiore, Pisa, Italy. He started at IBM Research – Zurich as a PhD student in 1993 before officially joining as a research staff member in 1998. His most recent position was Head of the Cognitive Computing and Computational Sciences department.

DR. NAVIN
RAMACHANDRAN

Radiology Consultant

University College London Hospital

DR. NAVIN
RAMACHANDRAN

Radiology Consultant

University College London Hospital

Dr. Navin Ramachandran is a practising radiology consultant at University College London Hospital, an honorary senior lecturer / healthcare data researcher at University College London Centre for Health Informatics & Multiprofessional Education and a co-founder of OpenCancer and the Platform for Enhanced Analytics and Computational Healthcare (PEACH). His main interests are in digital design, data modelling, interoperability, analytics, identity and consent management and he is also looking into the use of traditional blockchain in healthcare.

AMIR SAFFARI

SVP of AI

BenevolentAI

AMIR SAFFARI

SVP of AI

BenevolentAI

DR. BART GEERTS

Consultant Cardiac Anaesthetist & CEO

AMC & Healthplus.ai

DR. BART GEERTS

Consultant Cardiac Anaesthetist & CEO

AMC & Healthplus.ai

Dr. Bart Geerts is the founder and CEO of Amsterdam startup Healthplus.ai with tools to predict depression relapse through mobile app use, readmissions for chronic heart failure for cardiologists via home monitoring, 3D bone segmentation for orthopaedic and trauma surgeons and in-hospital infections.

 

He is an active physician and has over ten years of clinical experience as an anaesthetist, intensivist and clinical pharmacologist in the Netherlands and UK. He has managed a research group of more than ten scientists with a focus on medical technology and big data.

 

Bart has years in Pharma and AI. He has worked on several innovation projects in hospital consortia regarding digital health. He has studied medicine (MD), biomedical sciences (MSc), intensive care medicine (PhD), and global business (MBA at IE University).

DR. KAVEH SAFAVI

Senior Managing Director, Head of Global Health Practice

Accenture Health

DR. KAVEH SAFAVI

Senior Managing Director, Head of Global Health Practice

Accenture Health

Kaveh Safavi, M.D., J.D. is the senior managing director for Accenture’s global healthcare business. Dr. Safavi is responsible for developing and driving a growth strategy that differentiates Accenture’s offerings for providers, health insurers and public and private health systems across the globe.

Dr. Safavi joined Accenture from Cisco, in 2011, where he led the global healthcare practice. Prior to that, he was Thompson Reuter’s chief medical officer of its health businesses and United Healthcare’s vice president of medical affairs. He also has served in leadership roles at HealthSpring and Humana.

As a seasoned executive, Dr. Safavi brings more than three decades of leadership experience to Accenture Health including such accomplishments as establishing one of the Midwest’s first electronic health record-enabled primary care practices. He has published numerous papers and is quoted on healthcare issues in various media publications, including the Wall Street Journal, BBC, New York Times, U.S. News and World Report, Harvard Business Review and the Economist.

Dr. Safavi serves as a member of the board of directors for Xcertia, an organization that supports industry guidelines for safe and effective mobile health apps. He’s also serves on the advisory committee of the Buck Institute for Research on Aging.

Dr. Safavi has earned the distinction of both medical and law degrees, an M.D. from Loyola University School of Medicine and a J.D. from DePaul University College of Law. He is board-certified in internal medicine and pediatrics and completed his residency at the University of Michigan Medical Center.

Dr. Safavi is a lifelong Chicagoan.

ELENA BONFIGLIOLI

Managing Director, Health and Life Sciences EMEA

Microsoft

ELENA BONFIGLIOLI

Managing Director, Health and Life Sciences EMEA

Microsoft


KEY THEMES 2018

AI in R&D, clinical trial research and drug discoveries

AI in keeping well and preventative care

AI in early detection and diagnostics

AI in decision support, treatment and disease management

AI in genomics and precision/personalised medicine

AI in child health and mental health

GET READY TO BE INSPIRED

How many global health problems can we solve using AI?

How can we disrupt old systems from a reactive model to a preventative model?

From coding to cancer- how can AI make its mark in healthcare?

How can AI be used to do the legwork and speed up drug discovery?

What are the tech giants and AI startups working on to get deep learning into hospitals, clinics and smartphones?

How can we use AI to shape the way we handle our future well-being?

ATTENDEES

Pharma, Biotech and Medical Device/Tech Companies
Hospitals, Health Practices, Clinicians

Big Tech Companies
Health tech AI companies/ startups
Healthcare insurers
Academia
Investors

CEO, CTO, COO, CIO, Chief Data Officer
VP, SVP, Director, Head of, Managing Director, Head of

AI/ Machine Learning/ Computer Vision/ Cognitive Computing/Technology/ Innovation/Data Science/ Data Analytics/ Data Strategy

Clinician, Healthcare professional, Surgeon, Head of Oncology, Head of Surgery, Head of Cardiology, Head of Radiology

 

VIEW ATTENDEE LIST

ANA Avatar XPRIZE Competition

XPRIZE showcased ANA Avatar competition guidelines and current IBM Watson AI XPRIZE teams at Intelligent Health 2018

Calling all clinicians, developers, designers and project managers!

Do you want to enhance cancer screening, improve nursing, or reform hygiene through tech?
Do you want to transform the way vaccines or drugs are distributed or improve any other part of health?
Do you have a brain that wants to create and build field-level applications?

FIND OUT MORE

2018 HEADLINE SPONSOR

Novartis is a leading global medicines company based in Basel, Switzerland, with a history going back more than 150 years. We use innovative science, digital technology and new business models to address the evolving needs of patients and societies worldwide. Novartis products are available in about 155 countries and they reached nearly 1 billion people globally in 2017. About 120 000 people of more than 140 nationalities work at Novartis around the world.

www.novartis.com

 

2018 SPONSORS & PARTNERS

ADVISORS

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health

2018 SPEAKERS

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health

ABOUT THE ORGANISERS

Intelligent Health is brought to you by Inspired Minds, the organisers of World Summit AI; the most important event in the AI calendar. WSAI 2017 in Amsterdam, saw 2873 attendees from 72 countries listen to 140 speakers sharing their world view in 5 over-subscribed content streams, and was completely sold out. It was supported by all the major tech companies including Alibaba, Tencent, Facebook, Amazon, Google, NASA, Apple, Uber, Accenture, IBM Watson, Intel, and professors from New York University, Berkeley, Cambridge and many more.